For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. | The FDA is raising the bar for approval of CAR ...

The move towards a higher threshold for showing efficacy for new CAR-Ts comes after the FDA loosened the requirements for ...

Adults with type 2 diabetes or overweight or obesity who received GLP-1s do not have increased risk for obesity-related ...

At any given moment in time, more than 400 million individuals worldwide are battling depression. The antidepressant ...

Naoise Mac Giollabhui, PhD, of the Department of Psychiatry at Mass General Brigham, is the lead author of a paper published in American Journal of ...

The experimental drug neflamapimod reduced a key biomarker of neurodegeneration, which correlated with a slowing of cognitive ...

Canadian trial backs the routine use of tranexamic acid for major noncardiac procedures ...

Interview of a lead researcher performing hypnosis-based simulated surgery for weight loss with promising early results.

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

Tantalizing results from small trials and anecdotes raised hopes that drugs like Ozempic could help. Despite setbacks, ...

When neurologist Steven Arnold is deciding whether to treat an Alzheimer's patient with a new therapy, he relies on averages.